MedPath
NMPA Approval

Levocetirizine Dihydrochloride Oral Solution

国药准字H20254395

May 27, 2025

Drug Information

盐酸左西替利嗪口服溶液

口服溶液剂

75ml:37.5mg

化学药品

May 27, 2025

Company Information

Applicant Company

北京市顺义区天竺空港工业区A区天柱西路10号2幢3层

Manufacturing Company

北京市顺义区天竺空港工业区A区天柱西路10号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左西替利嗪口服溶液 - NMPA 批准文号 | MedPath